Cellus
Latest round
- Seed
Last raised
- Jun 2020
Total raised
- $1M
Investors
- 3
About Cellus
Based in Daegu, South Korea, and founded in 2020, Cellus is an innovative company that conducts cell experiments with new antibody drugs produced within a year of its establishment. Founded by Dr. Seong-geun Kim from the Department of Pathology in Gatrick Medical University and Professor Chosun-wook Cho of the Department of Endocrinology in Seoul National University Hospital to jointly develop a next-generation anticancer drug, the anti-cancer treatment strategy developed by the company has a modified function called Tumor-Associated Macrophage or TAM that deactivates cancer growth and metastasis rather than its original function. Based on this, an antibody therapeutics and low-molecular compound therapeutics that block the mechanism by which tumor-associated macrophages promote cancer cell metabolism has been developed. The company develops and manufactures anticancer drugs that overcome the shortcomings of low therapeutic effects of third-generation immunotherapy, which are currently the mainstay of anticancer drugs, use the relationship between immune cells and cancer cells in the cancer microenvironment to control factors that promote cancer growth and metastasis. Cellus plans to complete the initial production of four new drug substances under development within this year and conduct cell and mouse basic experiments in Korea.
Who invested in Cellus
3 investors across 1 round
See all investors in Cellus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 1, 2020
Amount
$1M
Investors
Questions about Cellus
Who invested in Cellus?
Cellus has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellus raised?
Cellus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellus last raise money?
Cellus's most recent round on record is a Seed, in Jun 2020.
What does Cellus do?
Based in Daegu, South Korea, and founded in 2020, Cellus is an innovative company that conducts cell experiments with new antibody drugs produced within a year of its establishment.
Where is Cellus headquartered?
Cellus is headquartered in Daegu, South Korea.
Which VCs invest in companies like Cellus?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, MPCi, Zijin Venture Capital and Legend Capital back healthcare companies at Cellus's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Cellus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.